Keyphrases
Cardiovascular Disease
27%
BCL6
27%
Therapeutic Cytokines
27%
Homing Receptors
27%
Cytokine Inhibitors
27%
Multi-epitope Vaccine
27%
Nanomedicine
27%
Disease Therapy
27%
Reverse Vaccinology
27%
Mycobacteroides Abscessus
27%
Mycobacterium Abscessus
27%
Hematological Indices
27%
Prognostic Role
27%
Immunogenic Activity
27%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
27%
Prophylactic Vaccine
27%
NFATc1
27%
T Cell Effector Function
27%
Heart Allograft
27%
Abatacept
27%
Anti-citrullinated Protein Antibodies
27%
Origanum Syriacum
27%
MDA-MB231 Breast Cancer Cell
27%
Activation Receptor
27%
CCR2
27%
Hantavirus
27%
Host-pathogen Interactions
27%
Computational Evaluation
27%
Immunoinformatics
27%
Gut Dysbiosis
27%
Psychobiotics
27%
Bystander
27%
COVID-19 Prevention
27%
Immune System
27%
B-modulation
27%
Delayed Acquisition
27%
Fresenius
27%
Antithymocyte Globulin
27%
Breg
27%
Behet's Disease
27%
ER Stress Response
27%
Rituximab Therapy
27%
NFAT5
27%
Aspartate Aminotransferase-to-platelet Ratio Index
27%
Platelet Ratio
27%
Allergic Contact Dermatitis
27%
Proteome Mining
27%
Long-term Repopulation
27%
SARS-CoV-2 Main Protease
27%
Structure-based Virtual Screening
27%
Drug Delivery Technology
27%
Advanced Drug Delivery
27%
Zika Vaccine
27%
Zika Virus
27%
Viral Pathology
27%
Peripheral T Lymphocytes
27%
Smart Solutions
27%
Receptor Revision
27%
Trained Immunity
27%
Interleukin-6 Inhibitors
27%
Anti-interleukin-6 Receptor
27%
Thymocyte Development
27%
Treatment Management
27%
Stress Inducers
27%
Vascular Inflammation
27%
Non-pharmaceutical
27%
Interleukin-6 Receptor (IL-6R)
27%
Chemokine Secretion
27%
Double-negative B Cells
27%
CD27
27%
Cell Control
27%
Functional Profiling
27%
Nutritional Additive
19%
COVID-19 Risk
18%
COVID-19 Infection
18%
COVID-19 Mortality
18%
Microbial Molecules
18%
T Lymphocyte Antigen
18%
Tc17
17%
Tocilizumab
16%
Helper T-lymphocytes
13%
Peptide Vaccine Design
13%
Ribosomal Protein L7
13%
Chemokine (C-C motif) Ligand 2 (CCL2)
13%
MM-PBSA
13%
Virology
13%
Nanodrug
13%
Theranostic Nanoparticles
13%
Exosome-based Drug Delivery
13%
Class-switched Memory B Cells
13%
Size Modification
13%
Engineering Nanoparticles
13%
Public Health Workers
13%
Design Industry
13%
Safe Integration
13%
Administrative Personnel
13%
Immunoglobulin Light Chains
13%
Design Productivity
13%
Industrial 4.0
13%
Performance Matrix
13%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Malignant Neoplasm
84%
Coronavirinae
61%
Infection
59%
Breast Cancer
54%
Monkeypox Virus
54%
SARS Coronavirus
46%
Vaccination Policy
42%
Angiotensin Converting Enzyme 2
32%
Monkeypox
30%
Adjuvant
30%
Dysbiosis
27%
Dengue
27%
Subunit Vaccine
27%
Origanum
27%
Epidermal Growth Factor Receptor
27%
Calcineurin
27%
Papillomavirus Infection
27%
Human Respiratory Syncytial Virus
27%
Polyphenol
27%
Multi-Epitope Vaccine
27%
Hantavirus
27%
Intestine Flora
27%
Burkitt's Lymphoma
27%
Cardiovascular Disease
27%
Antivirus Agent
27%
Factor A
27%
Triple Negative Breast Cancer
27%
Atopic Dermatitis
27%
Carnosol
27%
Human Papillomavirus
27%
Nanomedicine
27%
Vasculitis
27%
Vitamin D
27%
Reactive Oxygen Metabolite
27%
Aspartate Aminotransferase
27%
Smallpox Virus
27%
Respiratory Syncytial Virus Infection
27%
Aminotransferase
27%
Prebiotic Agent
27%
Atherosclerosis
27%
Anticoagulant Agent
27%
Herpes Simplex Virus
27%
HIV
27%
Zika Virus Vaccine
27%
Zika Fever
27%
Zika Virus
27%
Nanoparticle
27%
Antimicrobial Resistance
27%
Bacteriophage
27%
Vaccine Development
25%
Receptor
24%
Mixed Infection
18%
Virus Infection
18%
Vitronectin
16%
Diseases
14%
Physical Disease by Body Function
13%
Typical Antipsychotic
13%
Toll Like Receptor 3
13%
Probiotic Agent
13%
Cognitive Defect
13%
Fullerene Derivative
13%
Antiviral Therapy
13%
Hepatitis B Virus X Protein
13%
Pharmacotherapy
13%
Brain Derived Neurotrophic Factor
13%
Virus Pathogenesis
13%
Symptom
13%
Syndrome
13%
Disease Severity
13%
Side Effect
13%
Respiratory Tract Disease
13%
Antipsychotic
13%
Microorganism
13%
B Lymphocyte Receptor
11%
Hypovitaminosis D
10%
Vitamin D Deficiency
10%
Pandemic
10%
Antibiotics
9%
Remdesivir
9%
Viral Vector
9%
Phytochemical
7%
B Cell Lymphoma
7%
Lymphocyte Antigen
6%
Heparin
6%
Enoxaparin
6%
Nitric Oxide
6%
Psychotomimetic
6%
Human Immunodeficiency Virus 1
6%
Gelatinase B
6%
Gelatinase A
6%
Proline Rich Protein
6%
Combination Therapy
6%
Focal Adhesion Kinase
6%
Fibronectin
6%
Acquired Immune Deficiency Syndrome
6%
Vaccine
6%
Prostaglandin E2
6%
Integrin
6%
Proteasome
6%
Immunology and Microbiology
Monkeypox Virus
54%
Immune Response
36%
B Lymphocyte Subpopulation
31%
Vaccine Efficacy
30%
COVID-19
29%
Inflammatory Arthritis
27%
CCR2
27%
BCL6
27%
Dengue Fever
27%
Immune Disorder
27%
Dermatitis
27%
HBx
27%
Hantavirus
27%
Tacrolimus
27%
Origanum
27%
Reverse Vaccinology
27%
Host-Pathogen Interaction
27%
Abatacept
27%
Rituximab
27%
Anti-Thymocyte Globulin
27%
Skin Allergy
27%
Immune System
27%
Adoptive Immunotherapy
27%
Chimeric Antigen Receptor T-Cell
27%
Notch
27%
Host Factor
27%
Vasculitis
27%
Monkeypox
27%
Light Chain
27%
Platelet
27%
Atherosclerosis
27%
Thymocyte
27%
Herpes Simplex Virus
27%
Severe Acute Respiratory Syndrome Coronavirus 2
27%
Human Respiratory Syncytial Virus
27%
Interleukin-6 Receptor
27%
Respiratory Syncytial Virus Infection
27%
Immunoglobulin D
27%
Antimicrobial Resistance
27%
Bacteriophage
27%
Anti-Citrullinated Protein Antibody
24%
Contact Allergy
20%
Behcet Disease
18%
Transcription Factor NFAT
18%
B Cell
18%
Promoter Region
15%
Memory B Cell
15%
Hepatitis B Virus X Protein
13%
Hydrogen Bond
13%
Plasmablast
13%
Tocilizumab
13%
Viral Disease
12%
T Cell
12%
Infectious Disease
11%
CXCL10
10%
Immunopathology
9%
Regulatory B Cells
9%
Heredity
9%
Organ Transplantation
9%
Acute Graft Rejection
9%
Immune Receptor
9%
Aerobic Glycolysis
9%
B Cell Lymphoma Cell
9%
Mortality Rate
9%
NFAT
9%
CXCR4
7%
Peritonitis
6%
Opportunistic Infection
6%
Mycobacterium abscessus
6%
Sequenced Genomes
6%
In Ovo
6%
Immunoglobulin Production
6%
CXCL9
6%
Rheumatic Disease
6%
Vaccination Policy
6%
Splenic B Cell
5%
Human Papillomavirus Related Disease
5%
Listeriosis
5%
Cytoskeleton
5%
Immunological Synapse
5%
Graft-Versus-Host Disease
5%
Allogeneic Hematopoietic Stem Cell Transplantation
5%
Lyme Disease Vaccine
5%
